Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeted gene modification using triplex-forming oligonucleotides.

Jean Y Kuan1, Peter M Glazer

  • 1Department of Microbiology, Yale University School of Medicine, New Haven, CT, USA.

Methods in Molecular Biology (Clifton, N.J.)
|February 11, 2004
PubMed
Summary

Triplex-forming oligonucleotides (TFOs) are versatile tools for gene modification, capable of site-specific DNA damage and recombination. These molecules show promise for gene therapy and in vivo applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigating the role of mimosine-induced genotoxic stress through DNA repair profiling.

Molecular therapy. Nucleic acids·2026
Same author

Prenatal Intraportal Delivery of Polymeric Nanoparticles to Fetal Rhesus Monkeys (<i>Macaca mulatta</i>).

Human gene therapy·2026
Same author

Combining anti-gene γPNA with small molecules and RNA inhibitors: A strategy to enhance anti-tumor efficacy.

Molecular therapy. Nucleic acids·2026
Same author

PARP inhibitor resistance in IDH1-mutant cancers due to loss of end protection factors, 53BP1 and REV7.

NAR cancer·2025
Same author

Correction: Harnessing ExDNA for precision Exatecan delivery in cancer: a novel antibody-drug conjugate approach.

Molecular cancer·2025
Same author

Cell-penetrating antibody enhances nuclear delivery of triplex-forming oligonucleotides targeting HER2-positive cancers.

Molecular therapy. Nucleic acids·2025

Area of Science:

  • Molecular Biology
  • Genetics
  • Biotechnology

Background:

  • Triplex-forming oligonucleotides (TFOs) offer sequence-specific DNA binding.
  • TFOs can modulate gene expression and induce DNA alterations.
  • Their potential in gene therapy and in vivo applications is under investigation.

Purpose of the Study:

  • To review the binding requirements and chemical modifications for triplex formation.
  • To discuss the use of TFOs for gene inhibition and site-specific DNA damage.
  • To highlight TFOs' role in inducing recombination and their in vivo applications.

Main Methods:

  • Review of literature on TFO binding, chemical modifications, and applications.
  • Analysis of studies investigating TFOs for transcription inhibition.

Related Experiment Videos

  • Examination of research on TFOs inducing DNA damage and recombination.

    • Main Results:

    • TFOs exhibit sequence specificity and binding affinity for triplex formation.
    • Chemical modifications enhance TFO efficacy.
    • TFOs can inhibit transcription, induce site-specific DNA damage, and promote homologous recombination.
    • TFOs demonstrate mutagenic properties in cells with specific repair pathways.
    • Successful application of TFOs in cell culture and live animals for modifying chromosomal DNA.

    Conclusions:

    • TFOs are potent tools for site-specific gene modification.
    • TFOs have diverse applications including gene therapy and in vivo gene editing.
    • Further development of TFO technology holds significant promise for genetic manipulation.